Patents Assigned to Acton Biotech Consulting
  • Publication number: 20130184185
    Abstract: The present invention relates to methods for increasing the diversity of monoclonal antibodies produced against an antigen. The methods of the invention utilize immunization of a murine host defective in one or more enzymes involved in a post-translational modification of a polypeptide or a modification of a lipid, wherein said modification is exposed on a cell surface. The invention also relates to monoclonal antibodies produced by these methods and which are not produced when a normal mouse is immunized with the same antigen. The invention further relates to compositions comprising these monoclonal antibodies, as well as to such monoclonal antibodies bound or conjugated to a toxin, a detectable marker or to a solid support.
    Type: Application
    Filed: March 4, 2013
    Publication date: July 18, 2013
    Applicant: ACTON BIOTECH CONSULTING
    Inventor: ACTON BIOTECH CONSULTING
  • Patent number: 8389793
    Abstract: The present invention relates to methods for increasing the diversity of monoclonal antibodies produced against an antigen. The methods of the invention utilize immunization of a murine host defective in one or more enzymes involved in a post-translational modification of a polypeptide or a modification of a lipid, wherein said modification is exposed on a cell surface. The invention also relates to monoclonal antibodies produced by these methods and which are not produced when a normal mouse is immunized with the same antigen. The invention further relates to compositions comprising these monoclonal antibodies, as well as to such monoclonal antibodies bound or conjugated to a toxin, a detectable marker or to a solid support.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: March 5, 2013
    Assignee: Acton Biotech Consulting
    Inventor: Dale Anthony Cumming